Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 3, 2020

Study Completion Date

August 3, 2020

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

beclomethasone / formoterol / glycopyrronium

As this is a non-interventional study, all treatment decisions will be made at the discretion of the treating physician prior to enrolment in the study and during the entire period of the study. Treatment will be prescribed according to the product label in the summary of product characteristics.

Trial Locations (15)

2020

ZNA Middelheim, Antwerp

2650

Universitair Ziekenhuis Antwerpen, Antwerp

6000

Grand Hôpital de Charleroi, Charleroi

Unknown

GZA Campus Sint-Vincentius, Antwerp

Hôpital Erasme, Brussels

UZ Brussel, Brussels

Clinique Notre-Dame de Grâce ASBL Gosselies, Charleroi

UZ Gent, Ghent

AZ Groeninge, Kortrijk

CHR de la Citadelle, Liège

AZ Sint-Maarten, Mechelen

Hôpital André Vésale, Montigny-le-Tilleul

Clinique Saint-Luc Bouge, Namur

AZ Delta, Roeselare

Hospital Center De Wallonie Picarde, Tournai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Chiesi SA/NV

OTHER

NCT03627858 - Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting | Biotech Hunter | Biotech Hunter